Biopharma companies are diversifying their drug pipelines to support the growing global demand for lifesaving medications. These industry dynamics contribute to an acceleration in outsourcing efforts. Andrew Bulpin, Head of Process Solutions, joined Matthias Bucerius, Head of Actives & Formulation, to discuss 2022 emerging trends in the CDMO market.
